Teddy Scott

Teddy Scott is a Venture Advisor at Israel Biotech Fund. Dr. Scott is the CEO of Ethos Cannabis, founder and former CEO of PharmaCann. Under his vision and leadership, PharmaCann raised over $185M in the capital. In December 2018, PharmaCann entered into an agreement to be acquired by MedMen in a deal valued at $682 million.

As a registered patent attorney, Dr. Scott’s practice focused on a wide variety of patent licensing matters and intellectual property issues. Dr. Scott obtained his law degree from Northwestern University with a focus on business law.

Dr. Scott obtained his Ph.D. in molecular biophysics from the University of Texas Southwestern Medical Center.